OR WAIT null SECS
© 2023 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
Company News Release
Cardiocore, a centralized cardiac testing lab, announced its preferred provider status with a top 10 pharmaceutical company. Cardiocore was awarded cardiac safety service contracts in multi-year studies including a Thorough QT study and retrospective paper ECG analyses.
This is the company's second such announcement in the past three months. It had previously announced it was selected by an unnamed top 10 biotech.